Evolus, Inc. Common Stock
EOLS
Positions held
Your positionsEOLS isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $515.19M | Enterprise value | $634.83M | Trailing P/E | — | Forward P/E | 26.67 |
| PEG | — | Price / book | -16.67 | Beta | 1.34 | Dividend yield | 0.00% |
| Revenue growth | 21.2% | Earnings growth | — | Gross margin | 66.4% | Operating margin | -5.2% |
| Profit margin | -10.8% | ROE | — | ROA | -5.7% | Debt / equity | — |
| Current ratio | 1.70 | Free cash flow | -$1.82M | Analyst recommendation | none | Mean target | $15.00 |
| 52w high | $9.31 | 52w low | $3.86 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $84.1M | $73.1M | $90.3M | $69.0M | $69.4M |
| Op margin | -3.9% | -9.4% | -0.3% | -14.7% | -20.4% |
| Net income | -$8.1M | -$10.7M | $0.1M | -$15.7M | -$17.1M |
| Gross margin | 68.0% | 66.9% | 65.7% | 66.5% | 65.3% |
| Gross profit | $57.2M | $48.9M | $59.3M | $45.8M | $45.3M |
| Operating income | -$3.3M | -$6.9M | -$0.3M | -$10.2M | -$14.1M |
- Revenue +15% vs prior quarter ($84M vs $73M).
- Gross margin 68% (was 66.9% prior quarter).
- Operating margin expanded to -3.9%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $297M | $266M | $202M | $149M | — |
| Op margin | -12.7% | -10.2% | -22.3% | -40.1% | — |
| Net income | -$51.6M | -$50.4M | -$61.7M | -$74.4M | — |
| Gross margin | 66.3% | 68.5% | 68.1% | 60.4% | — |
| Gross profit | $197M | $182M | $138M | $89.8M | — |
| Operating income | -$37.6M | -$27.2M | -$45.0M | -$59.6M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · UTMD Trades at a Premium to the Industry: How to Play the Stock?
2026-10-02 · FDA Flags Evolus’ Jeuveau Instagram Promotion As Misleading, Seeks Corrective Action
2026-10-01 · Evolus Launches Wings by Evolus, a New Charitable Platform to Mobilize Its Community in Support of Important Causes
2026-09-09 · Evolus (EOLS) Notches A Profit Milestone While Betting Big On The Future
2026-08-31 · Telix Appoints David Gill as Chair
2026-08-27 · Wall Street Analysts Think Evolus (EOLS) Could Surge 77.68%: Read This Before Placing a Bet
2026-08-11 · Wall Street Analysts Believe Evolus (EOLS) Could Rally 106.08%: Here's is How to Trade
2026-08-06 · Evolus Inc (EOLS) (Q2 2026) Earnings Call Highlights: Revenue Surges 21% and Adjusted EBITDA ...
2026-08-06 · Evolus Q2 Earnings Call Highlights
2026-08-06 · Evolus, Inc. (EOLS) Reports Break-Even Earnings for Q2
Price (daily)
Full chart · RSI · MACD · patterns